Elgia Therapeutics Expands Management Team with Appointment of Stacie S. Canan, Ph.D. as Chief Operating Officer
Dr. Canan Brings 28 Years of Biopharmaceutical Experience, Including Research [...]
Elgia Therapeutics Announces New Funding to Develop Novel Treatments for Chronic Inflammatory and Fibrotic Diseases
Elgia Therapeutics, co-founded by multiple renown UCSD and UCSF [...]